OBJECTIVES: A large cohort of patients suffering from severe mitral regurgitation does not meet the indications for conventional surgery and would greatly benefit from a transcatheter approach in the beating heart. Consequently, off-pump transcatheter mitral valve procedures have been the focus of recent research. The aim of this study was the in vivo evaluation and comparison of subannular versus apical fixation of mitral valved stents to show the feasibility of subannular anchorage.
INTRODUCTION
Mitral regurgitation (MR) is the second most common valvular heart disease and has increasing prevalence with age [1] . The Euro Heart Survey showed that 30% of patients with severe single-sided valvular heart disease [1] and 49% of patients with severe MR are unsuitable for conventional heart surgery under cardiopulmonary bypass [2] . The main characteristics of these patients are comorbidities, impaired left ventricular ejection fraction (LVEF) and advanced age [2] . Owing to demographic changes, the number of these patients is predicted to increase further [3] , resulting in a growing demand for alternative, less-invasive treatment options in the beating heart. The development of a valved stent for transcatheter mitral valve implantation (TMVI) is the focus of current research with different prototypes undergoing first-in-man trials [4] [5] [6] [7] [8] [9] .
During the development process, various challenges need to be addressed. The valved stents should restore unidirectional forward flow and avoid paravalvular leakages (PVLs), spare the native chordal structures, prevent an obstruction of the left ventricular outflow tract (LVOT) and provide secure and reliable fixation in the dynamic high pressure system of the left heart. Thereby the fixation has to prevent stent migration within the complex anatomy of the native mitral apparatus. Particularly during systole -when high pressure is acting on the closed valve-migration into the left atrium must be avoided. Different stent fixation methods have been developed that can be divided into two major groups: apical fixation with a tethered fixation system [4] [5] [9] [10] [11] [12] and fixation acting directly at the annular or subannular level [6-8, correct length is of critical importance. If the neochords are too long, there is a high risk of migration and PVL. However, if they are too short, the longitudinal left ventricular (LV) function might be impaired. Even though a recent study has shown promising results with a normal longitudinal LV function and no PVL after implantation [12] , some effects are still unknown: so far, studies have been conducted in healthy hearts in the porcine model. In the diseased heart, positive LV remodelling could be possible, which might affect the stent fixation over time as ventricular dimensions decrease throughout the remodelling process. Direct fixation at the mitral annular level might provide some advantages and a combination of apical and annular fixation might give the most promising long-term results. Hence, a second prototype has been developed that provides direct subannular fixation in addition to the apical fixation system [15] .
The aim of this study was the in vivo evaluation and comparison of subannular versus apical fixation designs in the experimental model to show the feasibility of subannular anchorage.
Methods

Mitral valved stent design
Two different mitral valved stent designs were developed for the evaluation of different fixation techniques: stents with sole apical fixation and those with subannular fixation. Similar to earlier studies, the self-expanding nitinol stent frame (Euroflex GmbH, Pforzheim, Germany) of both prototypes was covered with a polytetrafluoroethylene (Zeus Inc., Orangeburg, SC, USA) membrane to reduce the risk of PVL. The stent frame was composed of an atrial element connected to a tubular ventricular body with a diameter of 32 mm at an atrioventricular angle of 110° [10] [11] [12] . A commercially available tri-leaflet bioprosthetic heart valve was sewn into the ventricular body and an apical fixation system consisting of four individual neochords (tethers) was attached to the ventricular rim of the stent.
The first prototype design (design AP; n = 12) was solely anchored apically (Fig. 1A) by affixing the tethered fixation system consisting of four individual neochords against an apical buttonlike counter bearing ( Fig. 2A and B) [12] . This prototype was designated as the control group, as this design has been previously presented and results of this population were partially included in previous studies [12] . In addition to the apical fixation system, the second design (design SA; n = 10) was anchored at a subannular level by making numerous outward bends in the ventricular stent (Fig. 1B) . After deployment, these were placed directly below the native mitral annulus to self-seat the valved stent and to fix the stent within the annular level against migration into the left atrium. In this early experimental stage, these stents were also apically anchored for additional fixation (Fig. 2C and D) .
Porcine in vivo model
The experimental implantations were carried out in our wellestablished porcine model [10] [11] [12] . Twenty-two pigs, German Landrace and German Edelschwein or their cross-breeds, with an average body weight of 49. 
Implantation of the valved stents
After introduction of preanaesthetia (ketamine 10% 10-15 mg/kg BW, midazolam 0.5-2 mg/kg BW), total intravenous anaesthesia ( propofol 2% 4-8 mg/kg BW, fentanyl 5-7.5 mg/h), intermittent positive pressure ventilation, ECG and invasive measurement of blood pressures (arterial catheter, central venous catheter, Swan-Ganz catheter) were conducted. Implantation of the mitral valved stent was performed through a lower ministernotomy that grants access to the apex of the heart in the porcine model. Two rows of pledgeted felt purse-string sutures were placed apically and a heparin bolus of 150 IU/kg body weight was administered intravenously.
The valved nitinol stent was crimped into the delivery system, introduced through the apex of the heart and implanted into the mitral annulus under 2D and 3D transoesophageal echocardiographic (TOE) guidance (Philips iE33 xMatrix, TEE-Probe X7-2t). To enable correct deployment of the stent, the tip of the delivery system (42 Fr) was moved into the mid-atrial position and particular attention was paid to ensuring correct orientation of the irregularly designed stents. The valved stents with subannular fixation elements were deployed in a three-step procedure. First, the atrial element was deployed to prevent migration into the left ventricle and secondly, the subannular nitinol triangles were released. Thirdly, after correct subannular positioning of the fixation elements, the ventricular element was fully deployed and the delivery system was removed from the heart. Stents with apical fixation were deployed in a two-step procedure as published previously [10] . First, the atrial element and then-in a second step-the ventricular element were deployed until the stent was fully unfolded. The delivery system was removed from the heart. The stent position in the mitral annulus and left atrium was adjusted under TOE guidance (Fig. 3) . Thereto, the occurrence of PVL was monitored while adjusting the fixation length of the neochordal apical fixation system. Correct position of the mitral valved stent was considered to be achieved when PVLs were minimized and the pulmonary capillary wedge pressure (PCWP) and the mitral annular plane systolic excursion (MAPSE) remained within physiological ranges.
Measurements
Full haemodynamic and echocardiographic evaluations were performed before and 1 h after valved stent implantation following a standardized protocol. The echocardiographic evaluation was conducted in standard as well as in non-standard views adapted to the pig's individual anatomy. In this study, the LVOT diameter is measured as the shortest distance between ventricular stent rim and ventricular wall using 2D echocardiography. The LVOT area is then calculated based on a simplified spherical model. Percent of Figure 2 : Schematic drawing and gross-evaluation image of (A and B) the apical fixation (AF) system consisting of four individual neochords affixed against an apical, button-like counter bearing (CB) and (C and D) the design with subannular fixation elements to be positioned directly below the mitral annulus and additional apical fixation.
narrowing of the LVOT is calculated using this simplified spherical area and the LVOT area directly below the aortic valve.
As previously published, the in vivo forces acting on the apical fixation of mitral valved stents were measured and analysed following successful stent deployment [15] .
Follow-up
Following deployment and stent positioning, the apical fixation system was knotted against a counter bearing located at the purse-string suture at the apex of the heart, and the thorax was closed. The animals were weaned from anaesthesia and brought back to the animal facility for further follow-up. The collective end-point of this study was the 1-h evaluation. Thereafter, the animals were observed up to 1 month depending on their wellbeing. Animals in poor condition were euthanized and those with excellent health underwent extended follow-up. Gross evaluation was performed focusing on the stent position and subannular fixation elements (area, height) and possible stent fractures.
Statistical analysis
Statistical analysis was performed using the SPSS 20 (SPSS Software, Germany). All results are expressed as means ± standard deviation. Significant variations of haemodynamic and echocardiographic parameters after valved stent implantation within the groups were identified using the dependent t-test. An inter-group comparison was conducted pair-wise using the Student's t-test. A Levene test was conducted to test the variance homogeneity. The probability of a type I error was set to 5% (α = 0.05).
Results
Valved stent implantation was successfully performed in 20 of 22 cases. In two cases (design SA: n = 2), ventricular fibrillation during the implantation procedure prior to full stent deployment led to massive infarction areas not related to the particular stent design. These animals were excluded from the evaluation.
Haemodynamic evaluation
Haemodynamic measurements (Table 1) revealed haemodynamic stability as well as a physiological PCWP after the implantation of the mitral valved stent that did not significantly increase after valved stent implantation. No significant changes in pulmonary artery pressure, central venous pressure and cardiac output (CO) were observed. However, a trend for improved CO and lower PCWP was detected in group SA.
Echocardiographic evaluation
Echocardiographic evaluation (Table 2 ) revealed a decreased mean LVEF after valved stent implantation in both groups (P ≤ 0.001). However, the EF had a physiological range of >50% in 9 of 12 cases in group AP and in 4 of 8 cases in group SA. A physiological MAPSE was observed 1 h after stent implantation, being reduced in group SA (P = 0.002). The mean gradients across the mitral valved stent were low in both groups. The gradients across the LVOT increased after valved stent implantation (P ≤ 0.04); however, no significantly increasing velocities over the LVOT were observed. Comparison of the preand post-implantation LVOT diameters revealed a free LVOT in 8 of 20 cases and a mildly obstructed LVOT (<25%) in 11 cases (Table 3) . Evaluation of PVL showed trace or less PVL in 19 of 20 cases (Table 3) . In one case, a mild PVL was detected (design AP: n = 1). Central mitral regurgitation (cMR) occurred more frequently, being mild in 7 cases. The severe cMR was associated with stent valve failure in 1 case. An adaptation of the circular stent shape to the native D-shape of the mitral annulus was observed during echocardiographic imaging.
Comparison of the haemodynamic and echocardiographic results did not reveal any statistically significant differences between the two groups.
Macroscopic evaluation
The mean survival time was 5 ± 5 days (range: 0-13 days) in group SA and 21 ± 21 days (range: 0-71 days) in group AP. Gross evaluation showed correct stent position in relation to the native mitral annulus in all cases, and in group SA stents properly self-seated within the annular plane by the fixation elements (Fig. 4) . The fixation elements were correctly placed in a subannular position in all but 2 cases. In these cases, a supra-annular or annular positioning of the fixation elements was detected. However, the fixation elements did penetrate the native leaflet tissue or myocardium. In one animal, infarction areas were detected in the left atrium above the subannular fixation elements.
Minor fractures of the stent frame occurred in 5 of 20 cases (SA: n = 3; AP: n = 2) and were mainly caused by folds of the ventricular or atrial element. Post mortem evaluation of these cases showed a dead fold with one or two broken nitinol struts in the ventricular or atrial element caused by the crimping procedure. Fractures of the subannular fixation elements were more common, being detected in 5 of 8 cases, in which the nitinol struts connecting the subannular elements to the ventricular stent body were broken to the degree that the elements were partly or completely detached from the ventricular element. Additionally, struts in close proximity to the subannular elements were broken in some cases. 
Discussion
To date, different devices for TMVI have been presented including tabs to connect to the basal myocardium and fibrous skeleton [6] , opposing, circumferential anchors to connect to the annulus and leaflets [7] , paddles for leaflet capturing [8] or an apical tether [9] [10] [11] [12] to achieve secure fixation. The first prototypes based on these different fixation systems have been implanted in first-in-man trials around the world with promising results [4-9, 16, 17] . In this study, a new mitral valved stent design with subannular fixation elements was compared with the previously published prototype with sole apical fixation to conduct a proof-of-concept.
Haemodynamic evaluation
Haemodynamic stability was achieved after valved stent implantation in all successfully implanted cases. Even though differences between the two groups were not significant, a trend of lower PCWP and higher CO was observed in group SA, which may indicate a positive effect of this design. Nevertheless, the average survival time of the animals in group SA was lower compared with that of group AP. We believe that the decreased survival time in group SA was due to the observed stent fractures. Furthermore, the subannular fixation elements penetrated the native heart tissue in most cases. Even though infarction areas were observed only in 1 case, this may have had a negative impact on the long-term outcome.
Echocardiographic evaluation
The decreased LVEF in both groups revealed the surgical impact on the healthy porcine hearts. This may be related to the susceptible nature of the porcine hearts and the healthy animal model. It can be expected that a new device in the mitral area is per se a source of irritation. In contrast, in the diseased hearts, this effect will be much lower due to the fact that the regurgitation is partially or fully reduced and the diseased hearts are already adapted to heavy congestion. Therefore, the device will be much more easily accepted. This observation is supported by the positive findings of the first-in-man trials [4] [5] [6] [7] [8] [9] but has to be further studied in the future. One main focus during the stent evaluation was the impact of the subannular fixation system on the physiological heart motion. The MAPSE provides important insight as it directly relates to the longitudinal function of the LV. Even though a statistically significant difference was observed for the SA group, the mean absolute values were identical to the AP group and no differences were identified between the two groups. We do not believe that the reduction of the MAPSE was relevant in terms of LV dysfunction as the MAPSE remained within a physiological range in the porcine model and there was no evidence of increasing impairment throughout the follow-up period. Furthermore, the unchanged velocity of flow progression, pulmonary vein flow and Tei-index indicated normal LV function. Only the decreased ratio of peak mitral flow velocities in the design SA and the increased left ventricular filling index may be signs of diastolic LV dysfunction. However, this has to be carefully considered in the presence of mitral stenosis or regurgitation.
The increased mean gradients across the mitral valve stent and the LVOT are most likely a consequence of the reduced mitral valve area. However, gradients across the valved stent, LVOT and aortic valve remained low within physiological ranges indicating good stent function. A reduction in the mitral valve area was observed in both groups as measured by the pressure half-time, being significant only in group SA. Even though a reduction of the opening area compared with the native area was detected, the stent showed good function and the animals were in good health after surgery. Devices with similar opening areas are commonly used during conventional surgical mitral valve replacement with good results.
A narrowing of the LVOT was observed in 12 of 20 cases. The calculation was based on the echocardiographic measurement of the minimal diameter between the ventricular stent rim and ventricular wall. This simplification overestimates the narrowing, as the dimension does not decrease in the perpendicular direction and the calculation is based on a sphere. Furthermore, the concept of a neo-LVOT created by the device, the interventricular septum and the anterior mitral valve leaflet was proposed, with a curved trajectory following the blood flow [18] . If this concept is applied to the measurement of the LVOT narrowing in this study, it is further overestimated. Therefore, we believe the real LVOT narrowing to be far less. This is supported by the good condition of the animals but has to be evaluated in detail in a future study.
Nineteen of 20 cases showed trace or less PVL. However, cMR of the stent was observed more frequently, causing a regurgitant volume after stent deployment. The cMR is most likely linked to the ovalizing of the valved stent observed in vivo. This results in deformation of the circular bioprosthetic heart valve and hence in cMR. Adaptation of the stent design will be necessary to achieve good paravalvular sealing with a beneficial oval outer shape but prevention of cMR. Other devices already follow this design [6, 9, 14]. As PVL is directly linked to the patients' wellbeing [19] , this is of critical importance for the overall outcome.
No significant differences in function between the two groups were identified at this point and both concepts showed adequate stent function at short-term follow-up, with haemodynamic stability, gradients within the physiological region and a similar MAPSE in both groups.
Gross evaluation showed better stent position of the design SA with subannular fixation elements, as the stent frame self-seats into the valvular plane while being supported by the subannular fixation elements. The occurrence of infarction areas has to be closely observed in future studies as this may be an issue of high importance. Fractures of the stent frame and mainly of the subannular fixation elements were a main issue of the design. We believe that the fractures of the single nitinol struts had a minor influence on stent function. However, the risk of dead folds causing these fractures has to be eliminated. The nitinol strut fractures in proximity to the subannular elements were critical, as these may have destabilized the stent frame. Most likely, the fractures caused the shorter survival time in the group SA. These fractures were likely a result of suboptimal mechanical frame properties and could be avoided using either thicker, more stable material or more struts.
In this study, a proof-of-concept was conducted for the subannular fixation system. However, different challenges and limitations have been identified (e.g. stent fractures or mechanical stiffness). These have to be addressed by a modified design. Areas of possible improvement include size and mechanical property adjustment to reduce fracture rates and improve myocardial penetration behaviour as well as adaptation of the overall stent shape and valve design to reduce central MR.
Study limitations
To date, experimental mitral valved stent implantation of the prototypes presented was carried out in healthy animals with nonregurgitant mitral valves. It will be of great interest to evaluate the impact of the mitral valved stent on diseased hearts with pathological echocardiographic parameters in future studies. Furthermore, this study included only an acute evaluation of the different fixation designs. Nevertheless, long-term effects are highly relevant for clinical application and have yet to be validated.
Conclusions
A proof-of-principle was conducted for the subannular fixation technique. Correct position of the valved stents, gradients across the valved stent within the physiological range and haemodynamic stability were achieved. Significant differences between the echocardiographic and haemodynamic parameters of the two groups were not observed in this study. The additional fixation elements at the subannular level were well tolerated and did not cause persisting arrhythmia. However, decreased diastolic function and EF were observed, and different design challenges, in particular stent fractures, sizing of fixation elements, stent expansion and oval shaping as well as potential for future improvement, have been identified. With regard to the long-term outcome, the group SA did not reach the results of group AP.
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